Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- GE Global Research Developing DNA Vaccine Technology to Enable Rapid Response to Infectious Diseases
- 6/21/2018 12:05:31 PM
- A team of GE scientists at GE’s Global Research Center in Upstate New York have been awarded a two-year, $4.7 MM program from DTRA, an agency within the U.S.
- Mitsui to Invest in Regenerative Medicine Company Organ Technologies Inc.
- 6/21/2018 11:55:52 AM
- Mitsui & Co., Ltd. ("Mitsui", Head office: Chiyoda-ku, Tokyo, President and CEO: Tatsuo Yasunaga), ITOCHU Corporation ("ITOCHU", Head office: Minato-ku, Tokyo, President and COO: Yoshihisa Suzuki) and Iyogin Capital Company Limited.
- DAT-Schaub buys pharmaceutical plant in the US
- 6/21/2018 11:33:41 AM
- There may seem to be no obvious connection between Danish Crown’s slaughtering of pigs, DAT-Schaub’s handling and processing of hog casings and the production of crude heparin, but the connection is actually staring us in the face.
- New long-term data confirm Roche’s Gazyva/Gazyvaro extends the lives of people with chronic lymphocytic leukaemia compared to MabThera/Rituxan
- 6/18/2018 12:14:39 PM
- • After a follow-up time of nearly five years the CLL11 study shows a 51% reduction in the risk of disease progression or death with Gazyva/Gazyvaro compared to MabThera/Rituxan • The final analysis reports a clinically meaningful overall survival benefit is seen for Gazyva/Gazyvaro compared to MabThera/Rituxan when combined with chlorambucil • These data highlight …
- ViiV Healthcare reports landmark phase III studies for dolutegravir and lamivudine, demonstrating the ability to control HIV with a two-drug regimen in treatment naïve patients
- 6/18/2018 12:10:08 PM
- ViiV Healthcare today announced positive headline results from its phase III GEMINI study programme. The studies (GEMINI-1 and GEMINI-2) are designed to evaluate the safety and efficacy of a two-drug regimen (2DR) of dolutegravir and lamivudine compared to a three-drug regimen of dolutegravir and two nucleoside reverse transcriptase inhibitors, tenofovir disoproxil …
- Eni signs agreement with Poison Control Centre at the ICS Maugeri Clinical Scientific Institute to make partnership global
- 6/15/2018 10:39:30 AM
- Eni and ICS Maugeri have signed an agreement to expand their partnership in toxicological emergency research, prevention and treatment to all the countries where Eni operates.
- GEA to supply contained tableting lines to top-tier Russian pharmaceutical company
- 6/15/2018 3:25:24 AM
- Commenting on the multi-million Euro deal, in cooperation with GEA’s representative in Russia, SolidPharma, Phil Gabb, Head of Solid Dosage Sales Support, GEA, said: “We are extremely pleased to be collaborating with Pharmasyntez and, in particular, with Mr Vikram Punia.
- Solvay’s high-stiffness Ixef® PARA enables Reign Medical to develop a more robust compression staple system for orthopedic and podiatric surgeries
- 6/14/2018 11:07:53 AM
- Solvay, a leading global supplier of specialty polymers, announced today that its Ixef® polyarylamide (PARA) resin delivered the high stiffness and biocompatibility that Reign Medical needed to develop its revolutionary new Clench® compression staple system, a single-use bone staple kit for orthopedic procedures targeting the hand and foot.
- Future Family Appoints Ex-SolarCity VP West Owens as Chief Financial Officer to Expand Its Subscription-based Fertility Service
- 6/13/2018 12:47:59 PM
- Today Future Family, the leading fertility care platform for consumers in the US, announces the appointment of West Owens as its Chief Financial Officer.
- Political Standoff in the Mediterranean Puts Vulnerable People at Risk
- 6/13/2018 12:39:57 PM
- UPDATE: The Aquarius has transferred rescued people to Italian coast guard and navy vessels, leaving 51 women, 45 men and 10 children onboard the Aquarius.
- Fujifilm Exhibits Pulmonary Products and Hosts Educational Forum at World Congress for Bronchology and Interventional Pulmonology
- 6/12/2018 9:30:00 AM
- (Booth #4) – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of endoscopic imaging solutions, is exhibiting its portfolio of pulmonary imaging devices at the 20th annual World Congress for Bronchology and Interventional Pulmonology and the World Congress for Bronchoesophagology (World Congress).
- Philips and Singapore Institute of Advanced Medicine Holdings open regional oncology center with advanced imaging solutions
- 6/8/2018 5:44:16 PM
- Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, and the Singapore Institute of Advanced Medicine Holdings (SAM) today officially opened the Advanced Medicine Imaging (AMI) center at Biopolis, an international biomedical research hub in Singapore.
- Erdafitinib Phase 2 Study Results Show Promise in the Treatment of Metastatic Urothelial Cancer
- 6/7/2018 3:49:03 PM
- The Janssen Pharmaceutical Companies of Johnson & Johnson announced findings today from a Phase 2 study that showed treatment with erdafitinib, a once-daily oral pan-fibroblast growth factor receptor (FGFR) inhibitor, resulted in durable responses in patients with metastatic or surgically unresectable urothelial cancer (mUC) and FGFR alterations (FGFRalt), a population with …
- Atlanta Legal Nurse Consultant Listens Up At Respiratory Compromise Talk
- 6/7/2018 10:00:00 AM
- Atlanta, GA – Atlanta legal nurse consultant Liz Buddenhagen, RN, attended a presentation by Jennifer Fruitticher, RN, Clinical Product Specialist at Medtronic, regarding respiratory compromise and carbon dioxide monitoring in Athens, Georgia on May 23, 2018.
- Consumers Beware: High User ‘Star Ratings’ Don’t Mean a Mobile Medical App Works
- 6/7/2018 2:46:44 AM
- Share Fast Facts • Disclaimers don’t prevent consumers from using apps for medical purposes. - Click to Tweet • App store user reviews from self-proclaimed health care professionals may not be reliable.
- Eosinophilic esophagitis may be due to missing protein
- 6/7/2018 2:43:00 AM
- What Scientists have discovered that the absence of a specific protein in cells lining the esophagus may cause inflammation and tissue damage in people with eosinophilic esophagitis (EoE). EoE affects as many as 150,000 people in the United States, many of whom are children.
- Borealis inaugurates EUR 15 million investment project mtm plastics GmbH
- 6/5/2018 12:58:43 PM
- Borealis, a leading provider of innovative solutions in the fields of polyolefins, base chemicals and fertilizers, announces the inauguration of a EUR 15 million investment project in mtm plastics GmbH.
- Peruvian rainforest plants have anti-malarial activity
- 6/5/2018 9:52:59 AM
- An Atlas-award winning study reported in the Journal of Ethnopharmacology has found that traditional uses of medicinal plants in the Peruvian rainforest are, to a large extent, backed up by science.
- Philips showcases end to end oncology informatics solutions at ASCO 2018
- 6/4/2018 12:57:49 PM
- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase a broad range of integrated oncology solutions, including IntelliSpace Genomics and IntelliSpace Oncology, to help support and scale precision medicine programs to assist oncologists with treatment decisions at the 2018 American Society of Clinical Oncology Annual Meeting (ASCO) …
- New Journal Series Provides Insights on European Medication-Related Guidelines
- 6/1/2018 1:48:03 PM
- A new series published in the British Journal of Clinical Pharmacology ( BJCP ) aims to help clinicians, researchers, and patients access and understand recent guidelines and regulatory documents issued by the European Medicines Agency (EMA), which oversees the scientific evaluation and safety monitoring of medicines in the European Union.
